ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 136 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $122 | -42.7% | 22,947 | +2.8% | 0.00% | – |
| Q2 2023 | $213 | -2.3% | 22,325 | +13.0% | 0.00% | – |
| Q1 2023 | $218 | -23.5% | 19,765 | +2.7% | 0.00% | – |
| Q4 2022 | $285 | -100.0% | 19,246 | -89.3% | 0.00% | -100.0% |
| Q3 2022 | $3,427,000 | -64.5% | 179,294 | -60.4% | 0.00% | 0.0% |
| Q2 2022 | $9,655,000 | +11.7% | 453,057 | +1.0% | 0.00% | 0.0% |
| Q1 2022 | $8,642,000 | -49.4% | 448,702 | -45.5% | 0.00% | -50.0% |
| Q4 2021 | $17,073,000 | -12.2% | 823,168 | +1.2% | 0.00% | 0.0% |
| Q3 2021 | $19,439,000 | -23.0% | 813,694 | -12.0% | 0.00% | 0.0% |
| Q2 2021 | $25,242,000 | +32.9% | 924,958 | +40.9% | 0.00% | 0.0% |
| Q1 2021 | $18,990,000 | +156.9% | 656,421 | +149.8% | 0.00% | +100.0% |
| Q4 2020 | $7,392,000 | -74.5% | 262,781 | -73.5% | 0.00% | -66.7% |
| Q3 2020 | $29,037,000 | -10.0% | 991,021 | -7.1% | 0.00% | -25.0% |
| Q2 2020 | $32,252,000 | +10.4% | 1,066,540 | +8.8% | 0.00% | -20.0% |
| Q1 2020 | $29,222,000 | – | 980,614 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|